Alkeon Capital Management - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 97 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2023$22,243,304
+23.8%
699,695
-5.0%
0.04%
-2.5%
Q1 2023$17,963,748
-46.5%
736,521
-30.8%
0.04%
-69.2%
Q4 2022$33,571,208
+1.7%
1,064,401
-8.9%
0.13%
+21.5%
Q3 2022$33,024,000
+3.1%
1,168,596
-3.5%
0.11%
+24.4%
Q2 2022$32,018,000
-46.1%
1,210,979
-28.7%
0.09%
-27.7%
Q1 2022$59,426,000
-4.0%
1,697,376
-11.1%
0.12%
+3.5%
Q4 2021$61,891,000
-32.9%
1,909,035
-38.9%
0.12%
-26.3%
Q3 2021$92,230,000
+36.0%
3,126,435
+18.1%
0.16%
+56.0%
Q2 2021$67,801,000
+182.2%
2,646,435
+51.2%
0.10%
+177.8%
Q1 2021$24,028,000
-17.2%
1,750,0000.0%0.04%
-23.4%
Q4 2020$29,015,0001,750,0000.05%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q3 2021
NameSharesValueWeighting ↓
BAIN CAPITAL INVESTORS LLC 60,199,729$1,314,160,08442.08%
Perceptive Advisors 10,088,385$220,229,4457.35%
Finepoint Capital LP 563,345$12,297,8216.12%
Affinity Asset Advisors, LLC 685,061$14,954,8824.21%
Paradigm Biocapital Advisors LP 2,532,972$55,294,7793.75%
Logos Global Management LP 700,000$15,281,0002.04%
Artal Group S.A. 1,638,858$35,7761.53%
Rock Springs Capital Management LP 2,529,116$55,210,6021.48%
GREAT POINT PARTNERS LLC 215,000$4,693,4500.86%
Frazier Life Sciences Management, L.P. 393,000$8,579,1900.57%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders